Page 4 - சிடார் மருத்துவ ஆராய்ச்சி News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Novamind Inc.: Novamind to Present at Benzinga Conference Psychedelics panel discussion to feature Novamind s Chief Medical Officer TORONTO, ON / ACCESSWIRE / February 23, 2021 / Novamind Inc. (CSE:NM) (OTC PINK:NVMDF) ( Novamind or the Company ), a leading mental health company specialized in psychedelic medicine, is pleased to announce its participation in the Benzinga Cannabis Capital Conference ( the Conference ), on February 25 th and 26 On Friday, February 26 th, 2021 at 1:30pm EST, Novamind s CEO and Director, Yaron Conforti, will present the Company s vision for scaling access to psychedelic medicine and advancing clinical research. We are excited to connect with investors who share our belief that innovative mental health therapies are disrupting the current standard of care in mental health, said Yaron Conforti, CEO and Director of Novamind. I look forward to this opportunity to share Novamind s approach to mental healthcare and clinical research in psychedelic m

Yaron confortiCedar clinical researchNovamind incChief medicalBenzinga cannabis capital conferenceChief medical officerReid robisonCedar psychiatryசிடார் மருத்துவ ஆராய்ச்சிதலைமை மருத்துவதலைமை மருத்துவ அதிகாரிரீட் கொள்ளைசிடார் மனநல மருத்துவம்